180 related articles for article (PubMed ID: 29584866)
1. Levels of Serum Brain-Derived Neurotropic Factor in Individuals at Ultra-High Risk for Psychosis-Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Yee JY; Lee TS; Lee J
Int J Neuropsychopharmacol; 2018 Aug; 21(8):734-739. PubMed ID: 29584866
[TBL] [Abstract][Full Text] [Related]
2. A Longitudinal Study of Serum Brain-Derived Neurotrophic Factor Levels in First-Episode Schizophrenia.
Yee JY; Lee TS; Lee J
J Clin Psychopharmacol; 2019; 39(6):639-643. PubMed ID: 31688384
[TBL] [Abstract][Full Text] [Related]
3. Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis.
Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Aktaş H
J Clin Psychopharmacol; 2015 Oct; 35(5):596-9. PubMed ID: 26267416
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.
Primavera D; Manchia M; Deriu L; Tusconi M; Collu R; Scherma M; Fadda P; Fratta W; Carpiniello B
BMJ Open; 2017 May; 7(5):e014938. PubMed ID: 28550022
[TBL] [Abstract][Full Text] [Related]
5. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
[TBL] [Abstract][Full Text] [Related]
6. Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.
Heitz U; Papmeyer M; Studerus E; Egloff L; Ittig S; Andreou C; Vogel T; Borgwardt S; Graf M; Eckert A; Riecher-Rössler A
World J Biol Psychiatry; 2019 Sep; 20(7):545-554. PubMed ID: 29938562
[No Abstract] [Full Text] [Related]
7. Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study.
Sanada K; de Azúa SR; Nakajima S; Alberich S; Ugarte A; Zugasti J; Vega P; Martínez-Cengotitabengoa M; González-Pinto A
Psychiatry Res; 2018 Oct; 268():1-7. PubMed ID: 29986171
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
9. Salivary cortisol in early psychosis: New findings and meta-analysis.
Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
[TBL] [Abstract][Full Text] [Related]
10. Serum brain-derived neurotrophic factor levels and psychotic symptoms in heroin dependence.
Han B; Zhang XY; Wang DY; Ren WW; Gu YY; Zhu L; Chang YL; Wang LP; Wu CW; Jin QQ; Chen C; Lyu DZ; Zhao JY; Shao B; He JC
Compr Psychiatry; 2015 Oct; 62():80-5. PubMed ID: 26343470
[TBL] [Abstract][Full Text] [Related]
11. Peripheral levels of superoxide dismutase and glutathione peroxidase in youths in ultra-high risk for psychosis: a pilot study.
Zeni-Graiff M; Rios AC; Maurya PK; Rizzo LB; Sethi S; Yamagata AS; Mansur RB; Pan PM; Asevedo E; Cunha GR; Zugman A; Bressan RA; Gadelha A; Brietzke E
CNS Spectr; 2019 Jun; 24(3):333-337. PubMed ID: 29248027
[TBL] [Abstract][Full Text] [Related]
12. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.
Jindal RD; Pillai AK; Mahadik SP; Eklund K; Montrose DM; Keshavan MS
Schizophr Res; 2010 Jun; 119(1-3):47-51. PubMed ID: 20096541
[TBL] [Abstract][Full Text] [Related]
13. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L
Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079
[TBL] [Abstract][Full Text] [Related]
14. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.
González-Pinto A; Mosquera F; Palomino A; Alberich S; Gutiérrez A; Haidar K; Vega P; Barbeito S; Ortiz A; Matute C
Int Clin Psychopharmacol; 2010 Jul; 25(4):241-5. PubMed ID: 20568658
[TBL] [Abstract][Full Text] [Related]
15. Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis.
Theleritis C; Fisher HL; Shäfer I; Winters L; Stahl D; Morgan C; Dazzan P; Breedvelt J; Sambath I; Vitoratou S; Russo M; Reichenberg A; Falcone MA; Mondelli V; O'Connor J; David A; McGuire P; Pariante C; Di Forti M; Murray RM; Bonaccorso S
Schizophr Res; 2014 Oct; 159(1):56-61. PubMed ID: 25171858
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study.
Singh J; Verma R; Raghav R; Sarkar S; Sood M; Jain R
Asian J Psychiatr; 2020 Dec; 54():102370. PubMed ID: 33271690
[TBL] [Abstract][Full Text] [Related]
18. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
[TBL] [Abstract][Full Text] [Related]
20. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study.
Nenadic I; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Reichenbach JR; Sauer H; Gaser C; Smesny S
Schizophr Res; 2015 Feb; 161(2-3):169-76. PubMed ID: 25497442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
